Photodynamic Therapy Market

Industry Outlook

The photodynamic therapy market is set to grow at an impressive rate, with a compounded annual growth rate (CAGR) of 5.7% during the forecast period from 2018 to 2026. As per the statistics provided by the World Health Organization (WHO), currently, 2 to 3 million non-melanoma and 132,000 melanoma cases of skin cancer occur throughout the globe annually. Photodynamic therapy (PDT) is a treatment option for treating disorders related to the skin and eyes. It involves the use of a photosensitizing drug that gets stimulated on exposure to light of a certain wavelength for the generation of radical oxygen species that are actively engaged in killing cancerous cells.

Market Synopsis

Negligible toxicity and the ability to produce reactive oxygen species to promote cell death in tumors drive the photosensitizer drug market.

Photosensitizer drugs are reigning as the dominant product segment in the photodynamic therapy market. The inherent attributes possessed by photosensitizer drugs, such as negligible toxicity and the ability to produce reactive oxygen species to promote cell death in cancerous cells, drive the photosensitizer drug market. Third-generation photosensitizers are available for the treatment of skin and eye disorders. They are used topically and intravenously for targeted cell destruction. Laser devices are required to stimulate the photochemical reaction after the administration of photosensitizer drugs. Laser diodes emitting wavelengths in the range of 733 nm are widely preferred in photodynamic therapy.

The increasing popularity of photoimmunotherapy propelled the oncology market

Presently, oncology is leading the application segment of the photodynamic therapy (PDT) market. Photoimmunotherapy is a treatment protocol that employs photodynamic therapy in conjunction with immunotherapy for tumor suppression. The combined therapy is useful in the stimulation of the immune system, which has a synergistic effect in the treatment of metastatic cancer. Photodynamic therapy also prevents cancer by shrinking blood vessels, which provide nutrients to the tumor. In dermatology, PDT is employed for the treatment of pathological conditions such as acne and psoriasis. PDT is being researched as an antimicrobial therapy due to its ability to kill various drug-resistant pathogens found on the skin surface and oral cavities. In ophthalmology, PDT is employed for the treatment of wet age-related macular degeneration (AMD), in which the photosensitizer drug (verteporfin) targets the neovasculature that is caused by AMD.

The rising prevalence of skin cancer will drive the photodynamic therapy market in North America.

In the current scenario, North America is dominating the regional segment of the photodynamic therapy market. According to the American Academy of Dermatology (AAD), one out of every five people in the United States will develop skin cancer during their lifetime. The rising prevalence of skin cancer and the increasing number of diagnostic centers drive the photodynamic therapy market in North America. In Europe, market growth is determined by factors such as the increasing number of people suffering from dermatological disorders and the domicile of major players such as Allergan, Plc., Galderma S.A., and Biofrontera AG, etc. Asia Pacific will be the fastest-growing market during the forecast period on account of developing healthcare infrastructure and market expansion opportunities for key players specializing in photosensitizer drugs and laser devices.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

Pharmaceutical companies actively engaged in providing products for photodynamic therapy are Allergan, Plc., Biofrontera AG, Biolitec AG, Dusa Pharmaceuticals, Galderma S.A., Lumenis, Ltd., PhotoMedex, Inc., Soligenix, Inc., Quest Pharmatech, Inc., and Valeant Pharmaceuticals International, Inc.

Key questions are answered in this report.

• What are the latest market trends in the photodynamic therapy market?
• What are the market participants involved in the photodynamic therapy market?
• What are the latest photosensitizer drugs and laser devices employed in photodynamic therapy?
• Which product is the fastest-growing in the photodynamic therapy market?
• Which application is the leading and fastest-growing in the photodynamic therapy market?
• Which regional segment is the leading and fastest-growing in the photodynamic therapy market?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global PT Market Portraiture
2.2. Global PT Market, by Product, 2017 (US$ Mn)
2.3. Global PT Market, by Application, 2017 (US$ Mn)
2.4. Global PT Market, by Geography, 2017 (US$ Mn)

Chapter 3. Photodynamic Therapy (PT) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global PT Market, by Key Players, 2017

Chapter 4. Global Photodynamic Therapy (PT) Market, by Product
4.1. Overview
4.2. Photosensitizer Drugs
4.3. Laser Devices

Chapter 5. Global Photodynamic Therapy (PT) Market, by Application
5.1. Overview
5.2. Ophthalmology
5.3. Oncology
5.4. Dermatology

Chapter 6. Global Photodynamic Therapy (PT) Market, by Geography
6.1. Overview
6.2. North America PT Market Analysis, 2016 – 2026
6.2.1. North America PT Market, by Product, 2016 – 2026 (US$ Mn)
6.2.2. North America PT Market, by Application, 2016 – 2026 (US$ Mn)
6.2.3. North America PT Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe PT Market Analysis, 2016 – 2026
6.3.1. Europe PT Market, by Product, 2016 – 2026 (US$ Mn)
6.3.2. Europe PT Market, by Application, 2016 – 2026 (US$ Mn)
6.3.3. Europe PT Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific PT Market Analysis, 2016 – 2026
6.4.1. Asia Pacific PT Market, by Product, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific PT Market, by Application, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific PT Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America PT Market Analysis, 2016 – 2026
6.5.1. Latin America PT Market, by Product, 2016 – 2026 (US$ Mn)
6.5.2. Latin America PT Market, by Application, 2016 – 2026 (US$ Mn)
6.5.3. Latin America PT Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa PT Market Analysis, 2016 – 2026
6.6.1. MEA PT Market, by Product, 2016 – 2026 (US$ Mn)
6.6.2. MEA PT Market, by Application, 2016 – 2026 (US$ Mn)
6.6.3. MEA PT Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Allergan, Plc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Biofrontera AG
7.3. Biolitec AG
7.4. Dusa Pharmaceuticals
7.5. Galderma SA
7.6. Lumenis, Ltd.
7.7. PhotoMedex, Inc.
7.8. Soligenix, Inc.
7.9. Quest Pharmatech, Inc.
7.10. Valeant Pharmaceuticals International, Inc.

List of Figures

FIG. 1 Photodynamic Therapy (PT) Market: Research Methodology
FIG. 2 PT Market Segmentation
FIG. 3 Global PT Market, by Product, 2017 (US$ Mn)
FIG. 4 Global PT Market, by Application, 2017 (US$ Mn)
FIG. 5 Global PT Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2017
FIG. 7 Competitive Analysis: Global PT Market, by Key Players, 2017
FIG. 8 Global Photosensitizer Drugs Market for Photodynamic Therapy, 2016 – 2026 (US$ Mn)
FIG. 9 Global Laser Devices Market for Photodynamic Therapy, 2016 – 2026 (US$ Mn)
FIG. 10 Global Ophthalmology Market for Photodynamic Therapy, 2016 – 2026 (US$ Mn)
FIG. 11 Global Oncology Market for Photodynamic Therapy, 2016 – 2026 (US$ Mn)
FIG. 12 Global Dermatology Market for Photodynamic Therapy, 2016 – 2026 (US$ Mn)
FIG. 13 U.S. PT Market, 2016 – 2026 (US$ Mn)
FIG. 14 Canada PT Market, 2016 – 2026 (US$ Mn)
FIG. 15 U.K. PT Market, 2016 – 2026 (US$ Mn)
FIG. 16 Germany PT Market, 2016 – 2026 (US$ Mn)
FIG. 17 Rest of Europe PT Market, 2016 – 2026 (US$ Mn)
FIG. 18 China PT Market, 2016 – 2026 (US$ Mn)
FIG. 19 Japan PT Market, 2016 – 2026 (US$ Mn)
FIG. 20 Rest of Asia Pacific PT Market, 2016 – 2026 (US$ Mn)
FIG. 21 Brazil PT Market, 2016 – 2026 (US$ Mn)
FIG. 22 Mexico PT Market, 2016 – 2026 (US$ Mn)
FIG. 23 Rest of Latin America PT Market, 2016 – 2026 (US$ Mn)
FIG. 24 GCC PT Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of MEA PT Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 Global Photodynamic Therapy (PT) Market Portraiture
TABLE 2 Global PT Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 3 Global PT Market , by Application, 2016 – 2026 (US$ Mn)
TABLE 4 Global PT Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America PT Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 6 North America PT Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 7 North America PT Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe PT Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 9 Europe PT Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 10 Europe PT Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific PT Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific PT Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific PT Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America PT Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America PT Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America PT Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East and Africa PT Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa PT Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East and Africa PT Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 Allergan, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Biofrontera AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Biolitec AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Dusa Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Galderma S.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Lumenis, Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 PhotoMedex, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Soligenix, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Quest Pharmatech, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Valeant Pharmaceuticals International, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)